13th PharmaLab Congress & Exhibition 2025

24th November 2025 - 26th November 2025

The event for all pharmaceutical laboratory sectors will cover various topics and lectures on analytics, bioanalytics and microbiology.

PharmaLab provides participants with the opportunity to exchange knowledge and experiences with representatives from authorities like EDQM, PEI, NIBSC/MHRA, AGES, industrial experts, and scientists from laboratories.

Congress delegates benefit from 9 parallel conferences, 2 pre-conference workshops with altogether over 100 presentations, 50 exhibitors in the exhibition and the networking event. An update in all relevant areas of pharmaceutical lab developments will be provided.

Cell & Gene Therapy International Europe 2025

01st December 2025 - 03rd December 2025

Cell & Gene Therapy International Europe is your key to accelerating advanced therapy development. Gain expert strategies to overcome development and manufacturing challenges, unlocking the full potential of your therapies. From emerging methods to decentralized manufacturing, get the knowledge you need to fast-track your pipeline and stay ahead in the ever-evolving field of advanced therapies.

Dates: 1st – 3rd December, 2025.

Location: Berlin, Germany.

7th Cell Therapy Analytical Development Summit 2025

01st December 2025 - 03rd December 2025

Description: As cell therapy programs advance into later clinical stages and regulatory scrutiny tightening, early analytical strategy has never been more important.

It is in the shadow of these changes, that the 7th Cell Therapy Analytical Development Summit returns to unite the field. From designing assays that can withstand validation, streamlining tech transfers and decoding mechanisms of action from day one, to building robust, predictive, and compliant analytical frameworks, this year’s program will prepare you for the next wave of analytical hurdles.

9th Complement-Based Drug Development Summit 2025

01st December 2025 - 03rd December 2025

The Complement-Based Drug Development Summit returns for its 9th year to unite the leading experts in complement biology and therapeutic development, from innovative biotech to impactful large pharma and academic experts.

Join 80+ experts at the 2025 meeting to gain insights from 20+ expert speakers covering the end-to-end complement-based drug development, from basic biology to diagnostics and clinical development.

This comprehensive program spans a broad spectrum of renal, ophthalmic, neurological, and haematological indications, mirroring the shift in focus of the complement field from rare orphan indications to larger patient populations.

4th LNP Immunology & Toxicity Summit 2025

03rd December 2025 - 03rd December 2025

The 4th LNP Immunogenicity & Toxicity Summit returns in December, as an industry-dedicated virtual forum, bringing you the key updates on pre-clinical and clinical safety assessments and assays to effectively measure and monitor LNP safety for gene and cell therapies and vaccine applications.

This year’s exclusive one-day program will provide you with an entire day of scientific progress and technical insights into LNP mechanism of action, translational animal model approaches, and pharmacokinetic and dynamic studies to support the prediction, dosing strategy, and improve clinical effectiveness of pegylated and ionizable LNPs across all payloads.

Log on to the platform from the comfort or your home or office and connect with 80+ fellow LNP experts spanning non-clinical and clinical safety, from immunology, toxicology, pharmacology, and bioanalytics to learn, share, and network virtually to support the development of safer LNPs for patients faster.

INJECTA Summit 2025

03rd December 2025 - 04th December 2025

Injecta Summit is the premier event uniting professionals from the pharmaceutical, medical device, and healthcare sectors in an exploration of the latest advancements in pre-filled syringes, injectable drug devices, and parenteral systems.

Our summit is a vital hub for industry experts, decision-makers, and innovators to exchange insights, discuss regulatory compliance, delve into patient-centric design, explore emerging technologies, and address sustainability.

3rd Cell Therapy for Autoimmune Disease Summit 2025

02nd December 2025 - 04th December 2025

Description: The 3rd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia at a pivotal time for this field, as autoimmune cell therapies stand poised for clinical and commercial success.

As cutting-edge innovations redefine the chronic care of autoimmune indications, reconnect with 30+ pioneering speakers as they unveil the latest preclinical and clinical data spanning CAR-T, Treg, in vivo and NK cell therapies to propel your lead candidate to the clinic.

Join us this December to take your place at the head of autoimmune cell therapy development!

2nd Cell & Gene Therapy Regulatory Affairs Summit 2025

02nd December 2025 - 04th December 2025

With major FDA changes already reshaping the regulatory landscape – and global agencies ramping up scrutiny – 2025 is a pivotal year for cell and gene therapy regulatory professionals. With CBER leadership changes, new FDA draft guidance on post-approval CMC, and potency assays facing heightened scrutiny, the environment is rapidly evolving. Global efforts to align expectations are also gaining momentum, with ANVISA and Health Canada joining harmonization initiatives, and ICH Q12 implementation for CGTs underway.

The 2nd Cell & Gene Therapy Regulatory Affairs Summit is the only industry-led event focused exclusively on CGT regulatory strategy. Join 80+ experts this December in Washington, D.C. for real-world case studies, insights from regulators, and deep dives into IND-to-BLA planning, global alignment, and emerging modalities.

If you’re navigating nonclinical, clinical, or CMC submissions, this is your essential forum to stay ahead of shifting expectations and accelerate CGT approvals in 2025 and beyond.

Find out more, continue reading…

8th RNA-Targeted Drug Discovery & Development Summit 2025

02nd December 2025 - 04th December 2025

RNA-targeting small molecules are rapidly emerging as a powerful therapeutic reality. From modulating splicing to directly binding RNAs, these molecules offer a revolutionary approach to treating previously undruggable diseases across neurodegenerative, cancer and rare disorders. In 2025 alone, the field has seen major collaborations, including Wayfinder Biosciences with Daiichi Sankyo, Ono Pharmaceutical with Reborna Biosciences, and xFOREST with Astellas Pharma—signaling growing momentum and industry confidence.

Now in its 8th year, the RNA-Targeted Drug Discovery & Development Summit returns as the only dedicated industry forum addressing the unique challenges of RNA-targeted drug development across splice modulators, covalent drugs, proximity inducers and direct RNA binders.

Join 25+ world-class speakers from leaders like PTC Therapeutics, ReviR Therapeutics, Remix Therapeutics, Rgenta Therapeutics, Arrakis Therapeutics and more this December to gain the connections, tools and scientific firepower needed to bring your RNA-targeted therapeutics to clinic and beyond.

14th Tumour Models Summit London 2025

03rd December 2025 - 04th December 2025

With the European preclinical oncology market projected to boom to $22.3 billion by 2033 led by the enhanced focus across targeted and next-generation immunotherapies, the heightened regulatory push from the FDA, and the EMA encouraging the use of non-animal methods including organoids and AI-based computational models in submissions, the need to understand which models are better at recapitulating the patient context has never been greater.

Built by biopharma for biopharma, the 14th Tumour Models Summit London returns this December to provide an update on tumour model advancements, and how to approach model selection and de-risk oncology drug development before entering the clinic.

Bioverse Europe 2025

04th December 2025 - 05th December 2025

Bioverse Europe 2025 is the leading conference at the convergence of artificial intelligence, computational biology, and multi-omics science. This event brings together experts advancing machine learning for biomarker discovery, AI-driven drug development, and predictive modelling of complex biological systems.

Explore how next-generation algorithms are accelerating breakthroughs in genomics, single-cell analysis, spatial transcriptomics, and digital pathology.

Join a global community of scientists, technologists, and innovators shaping the future of AI-powered biology and precision medicine.

12th Digital Pathology & AI Congress: Europe 2025

10th December 2025 - 11th December 2025

This internationally recognised meeting is the only meeting truly focused on the transformative power of Digital Pathology and the advances created by Artificial Intelligence and Machine Learning. Across the health sector and pharmaceutical/biotech industry, the adoption of digital pathology is speeding up. It’s impact is being felt in primary diagnosis and clinical research as well as the laboratory.

Realisable benefits include:

1. Enhanced Diagnostic Accuracy
2. Increased Workflow Efficiency
3. Accelerated Drug Discovery
4. Improved Patient Outcomes
5. Cost Savings

Date: 10 Dec 2025 to 11 Dec 2025

Location: London, UK

2nd ADC Pharmacokinetics & Clinical Pharmacology Summit 2025

09th December 2025 - 11th December 2025

Bringing together leaders in PKPD, bioanalysis, pharmacometrics, and clinical pharmacology, the 2nd ADC Pharmacokinetics & Clinical Pharmacology Summit will address the industry’s most pressing challenges, providing a focused environment to:

• Translate preclinical PK data into more predictive first-in-human dose selection
• Address dosing considerations for novel and complex ADC formats
• Consider strategies for dosing ADCs in combination settings
• Navigate dose selection strategies and adapt to Project Optimus

As we combine data sharing with real-world dose optimization and dose modification case studies, join this timely forum to engage in practical discussion and knowledge sharing to support better dosing decisions in ADC pharmacokinetics and clinical pharmacology, and ultimately, more efficient delivery of safe and efficacious ADCs to patients.

See the event guide here…

Oligonucleotide-based Therapeutics Summit 2025

09th December 2025 - 11th December 2025

The Oligonucleotide-based Therapeutics Summit is uniting leaders in RNA chemistry, delivery science, and translational biology to advance oligonucleotides as a pioneering therapeutic class.

This December in Boston, unite with leading experts from Secarna, Genentech, Avidity Bioscience, Dyne Therapeutics, Biogen, Novo Nordisk, Stoke Therapeutics, and more as they reveal cutting-edge insights spanning discovery to late-stage development.

2nd GPCRs-Targeted Drug Development Summit 2025

09th December 2025 - 11th December 2025

GLP-1 receptor agonists in obesity has reignited investment, innovation, and clinical exploration across the GPCR space. With major deals such as Eli Lilly’s $1.3 billion collaboration to advance small-molecule GPCR therapeutics using AI- and ML-powered platforms, momentum is building fast, making 2025 a pivotal year to be part of this rapidly evolving field.

Returning as the only meeting dedicated exclusively to GPCR drug discovery and development in Europe, the 2nd Annual GPCR-Targeted Drug Discovery Summit Europe brings together the brightest minds in biopharma to translate this momentum into actionable strategies.

Event Dates: 9th-11th December, 2025

Location: London, UK

LEAP TD: Life Sciences 2025

08th December 2025 - 12th December 2025

As biopharma organizations decrease their budgets and move away from a recruitment-centric approach, the need to develop existing talent to fill key technical skills gaps has never been more mission critical.

Join LEAP TD: Life Sciences to transform your L&D strategy to develop and retain a highly skilled, agile scientific while building a resilient leadership pipeline to accelerate innovative research and development. This is your opportunity to rethink how learning, leadership, and a renewed focus on strategic workforce planning can drive measurable business impact, commercial, and scientific success.

Non-Opioid Pain Therapeutics Summit 2026

27th January 2026 - 29th January 2026

For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market.

Whether advancing NaV-targeting drugs or pursuing novel pain mechanisms, non-opioid therapeutics are now in the clinical spotlight and the next 12 months promise to be transformative.

The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness that momentum. Attendees will be learning from companies with approvals such as Tonix, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join 70+ discovery, preclinical, translational and clinical industry-based experts driving the future of non-opioid pain therapies across diverse pain indications.

6th Age-Related Disease Therapeutics Summit 2026

27th January 2026 - 29th January 2026

Join the global biopharma community at the 6th Age-Related Disease Therapeutics Summit, taking place January 27–29, 2026, in San Francisco. This industry-leading event is your gateway to the latest breakthroughs in aging biology, translational science, and clinical innovation, designed to accelerate the development of safe, effective, and regulatory-compliant therapeutics targeting age-related diseases.

With aging biology now at a critical inflexion point, the summit arrives at a time of unprecedented momentum. Landmark deals like Novartis’ $550M alliance with BioAge Labs and Chugai’s $250M AI-driven partnership signal a surge of investment and clinical activity. Aging-targeted therapeutics, from senolytics and partial reprogramming to repurposed GLP-1s, are stepping out of the lab and into the clinic, and this summit offers a dedicated platform to harness that momentum.

Expect to hear from over 20 world-class speakers including:

• Jeremiah Bearss, VP of Clinical Development at Biolexis Therapeutics
• Peng Leong, Head of Brain Aging & Chief Business Officer at BioAge Labs
• Alexander Pickett, Managing Director at Juvenescence
• Anne-Ulrike Trendelenburg, Executive Director at Novartis
• Joseph Rayman, Principal Investigator at Columbia University

These thought leaders will share cutting-edge insights into drug development strategies, biomarker innovation, delivery mechanisms, and regulatory pathways.

To view the full agenda, continue reading…

7th RNAi-Based Therapeutics Summit 2026

27th January 2026 - 29th January 2026

The 7th RNAi-Based Therapeutics Summit is the industry’s premier forum uniting 80+ senior leaders to conquer the final frontier of extrahepatic delivery for neurological, metabolic, cardiovascular, and oncological diseases.

Whether you’re navigating discovery to IND-enabling studies, tackling clinical development, or strategizing for approval, don’t miss your chance to connect with senior scientists, heads of, directors and C-level experts in discovery, pre-clinical, chemistry, molecular biology, and CMC to redefine the next chapter of RNAi therapeutics.

Want to learn more about this RNAi opportunity? Continue reading to access your free event guide today…

9th DDR Inhibitors Summit 2026

27th January 2026 - 29th January 2026

The 9th DDR Inhibitors Summit returns to Boston in 2026 as the leading event uniting biopharma, biotech, and academia to advance next-generation DNA Damage Response (DDR)-targeted therapies beyond PARP.

With growing clinical momentum for ATR, CHK1/2, WEE1, and DNA-PK inhibitors, this 3-day meeting delivers cutting-edge insights on biomarker-driven discovery, translational strategy, and combination approaches.

Featuring 30+ expert speakers from Artios Pharma, AstraZeneca, Merck, and others, attendees will benchmark programs, explore innovations, and network with global DDR leaders shaping the future of precision oncology through synthetic lethality and safer, more effective cancer treatments.

4th Ophthalmic Drug Delivery Summit 2026

27th January 2026 - 29th January 2026

As the global burden of retinal and ocular diseases continues to rise, the race to develop safer, longer-lasting, and less invasive treatments is accelerating, and at the heart of that challenge lies drug delivery. The 4th Ophthalmic Drug Delivery Summit arrives at a pivotal moment, bringing together 80+ leading experts from pharma and biotech to tackle the toughest delivery hurdles limiting the impact of cutting-edge therapeutics.

With industry momentum building around sustained-release technologies, suprachoroidal administration, and innovative device-drug combinations, this summit is your gateway to the breakthroughs redefining ocular treatment. From translating long-acting formulations into clinical success to navigating regulatory complexities early, this is the only event dedicated to transforming how and where ophthalmic therapies work – making it a must-attend for anyone shaping the future of eye care.

5th mRNA Based Therapeutics Summit Europe 2026

27th January 2026 - 29th January 2026

The 5th mRNA-Based Therapeutics Summit Europe is the leading industry forum uniting 170+ global experts across R&D, CMC, Regulatory, Clinical, and Business Strategy to accelerate the safe, scalable, and impactful development of mRNA medicines.

The 2026 agenda explores mRNA’s expansion beyond infectious diseases into oncology and rare disorders, while tackling key challenges in delivery, stability, and next-generation modalities like saRNA and circRNA. New for 2026, a Gene Editing Focus Day highlights mRNA’s role in safer, transient editing and regenerative medicine.

Investor sessions will also reveal the clinical, strategic, and financial benchmarks defining mRNA’s path to commercial and investment success.

14th Alzheimer’s & Parkinson’s Drug Development Summit 2026

03rd February 2026 - 05th February 2026

Capitalizing on the surge of innovation across new targets, lessons learned from clinical setbacks, groundbreaking progress in blood-based diagnostics, and more, the 14th Alzheimer’s & Parkinson’s Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical and regulatory.

In its 14th year, the Alzheimer’s and Parkinson’s Drug Development Summit is committed to spotlighting the latest trailblazing innovation, from novel interventions for disease modification, encompassing protein aggregation, neuroinflammation, metabolic pathways, neurotrophic factors and more to the groundbreaking progress in p-tau217 and fluid-based biomarkers.

The 2026 program is built to explore disease progression, modification and prodromal intervention, so the next generation of therapeutics can prevent as well provide a meaningful impact to neurodegenerative patients in need.

10th Liquid Biopsy for Precision Oncology Summit 2026

03rd February 2026 - 05th February 2026

The 10th Liquid Biopsy for Precision Oncology Summit is the leading annual meeting for pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy.

Now in its 10th year, this meeting delivers unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline – from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption.

If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in your conference calendar. Across ctDNA, MRD, multi-omic biomarkers, and novel analytes, you will see how pharma are strategically integrating liquid biopsies into therapeutic pipelines, how diagnostic companies are designing more sensitive assays, and how the field is overcoming barriers to widespread clinical adoption.

2nd Proteomics-Based Drug Discovery Summit 2026

03rd February 2026 - 05th February 2026

With major deals like Novartis’ $750M partnership with ProFound Therapeutics and Illumina’s $425M acquisition of SomaLogic, proteomics is rapidly emerging as a transformative force in drug discovery.

Returning to Boston for its second year, the Proteomics-Based Drug Discovery Summit unites 70+ leaders in proteomics, chemical biology, mass spectrometry, and bioinformatics. Attendees will explore how next-generation proteomic platforms accelerate target discovery, pathology understanding, and hit-to-lead development.

With sessions on optimizing instruments, automating workflows, PTM analysis, and establishing gold-standard methodologies, this premier forum will empower innovators to expand the druggable proteome and drive breakthroughs for diseases with unmet clinical needs.

Structure-Based Drug Design Summit 2026

03rd February 2026 - 05th February 2026

The Structure-Based Drug Design Summit West brings together leaders in computational chemistry, structural biology, and AI-driven discovery to advance rational drug design and precision therapeutics.

This premier meeting showcases breakthroughs in molecular modeling, cryo-EM, fragment-based design, and machine learning transforming small-molecule and biologic development. Engage with scientists, biopharma executives, and technology innovators to exchange insights, build collaborations, and accelerate structure-guided innovation.

From target validation to lead optimization, the summit delivers the scientific depth, practical strategies, and networking opportunities needed to translate cutting-edge structural and computational approaches into impactful drug discovery and development success.

16th World ADC London 2026

23rd February 2026 - 26th February 2026

Returning as the longest-standing and definitive ADC forum in Europe, the 16^th World ADC London Summit is the week for anyone working in or interested to learn about bioconjugates. Leverage cutting-edge R&D, development strategy, and unparalleled networking opportunities to harness ADC innovation and maximise the therapeutic index of your ADCs.

With 5 streams of end-to-end content spanning discovery, preclinical and translation, clinical lessons, process and analytical development, and manufacturing and supply chain: the 2026 agenda has been infused with trailblazing design, development, and production innovations to overcome patient resistance mechanisms and push ADCs to earlier line oncology treatments.

Uniting 800+ senior European ADC decision-makers across biopharma, clinicians, service providers, investors, and regulators, World ADC London is proud to bring the community together to kick off 2026 and shape the future of ADC development.

LEAP HR: Life Sciences Europe 2026

24th February 2026 - 26th February 2026

Now in its 8th year, LEAP HR: Life Sciences Europe is where the industry’s most ambitious HR leaders come together to find new solutions to their most pressing people challenges that they can immediately deploy to demonstrate meaningful business impact. Attend to uncover the boldest strategies for driving talent agility, embedding AI and analytics, and building future-ready workforces – proven to cut costs, boost engagement, and accelerate growth.

Across three value-packed days, you’ll connect with peers who are reimagining HR’s role as driver of strategic value and organizational impact, sharing real-world case studies, practical solutions, with the ROI behind every leap.

World EPA Congress Europe 2026

03rd March 2026 - 04th March 2026

World EPA Congress Europe 2026 is the world’s largest and most crucial gathering dedicated to pharmaceutical market access, pricing strategies, and generating robust evidence. It serves as a vital platform for limitless networking, bringing together over 1,500 attendees from pharma, biotech, and key Payers/HTAs (Health Technology Assessment bodies).

The event is structured across 10 tracks, focusing on critical industry challenges, including evolving reimbursement models, the complexities of accessing treatments for Rare Diseases, the strategic implications of the EU Joint Clinical Assessment (JCA), and leveraging Real-World Evidence (RWE) and AI to define the value and access of innovative medicines across Europe.

Code BPA20 for an extra 20% off

LSX World Congress Europe 2026

25th March 2026 - 26th March 2026

For over a decade, the LSX World Congress Europe has been bringing together the executives that matter to the future of healthcare and life science investment, strategy and partnering.

Gathering the founders and CEOs of innovative start-ups through to public healthcare giants. It represents the breadth and depth of cutting-edge research and technology driving the advances in the industry right now and in the near future.

PCR and NGS in Modern Diagnostics 2026

31st March 2026 - 01st April 2026

The conference will showcase cutting-edge developments in PCR and sequencing, featuring the latest in digital PCR, single-cell analysis, long-read technologies, and high-throughput automation.

Sessions will explore key clinical and translational applications, including oncology, infectious diseases, and rare genetic disorders. With the rapid rise of bioinformatics and AI, the programme also highlights advanced approaches for data analysis, variant interpretation, and AI-enabled diagnostics.

Beyond clinical use, the event expands into applied genomics, covering breakthroughs in microbiome research, plant pathology, antimicrobial resistance, and environmental genomics—bringing together experts across disciplines to discuss impactful innovations shaping the future of modern diagnostics.

Date: 31 Mar – 1 April 2026

Location: K Lumpur, Malaysia

World Vaccine Congress Washington 2026

30th March 2026 - 02nd April 2026

The World Vaccine Congress Washington 2026 is the largest and most established global meeting dedicated to the entire vaccine value chain, spanning from fundamental research to commercial manufacturing and equitable global access. Scheduled for March 30 – April 2, 2026, at the Walter E. Washington Convention Center, this vital event unites over 4,000 attendees from science, government, and industry.

It aims to drive groundbreaking progress and essential partnering in the sector. Key focus areas include Pandemic Platforms, Cancer & Immunotherapy, Emerging Infectious Diseases, Clinical Trials, and Bioprocessing, fostering discussions crucial for the future development and delivery of vaccines worldwide.

Continue reading to use code BPA20 for an extra 20% off.

4th Cell & Gene Therapy Innovation & Access Congress 2026

09th April 2026 - 10th April 2026

Now in its fourth year, the event returns with strong demand and a refreshed focus covering the full cell and gene therapy pipeline—from early-stage research to manufacturing and scalability. Over two days, the conference will bring together 30+ expert speakers and more than 150 participants, supported by an exhibition and networking area featuring 20+ sponsors and solution providers.

The programme runs across two dedicated tracks: Therapeutic Discovery & Engineering, highlighting innovations in gene therapy and next-generation cell therapies; and Manufacturing Enablement & Translation, focusing on advances in gene therapy manufacturing and scalable solutions for cell therapy production.

Date: 9-10 April 2026

Location: Seoul, South Korea

11th Microbiome R&D and Business Collaboration Congress and 2nd Skin Health & Microbiome 2026

29th April 2026 - 30th April 2026

The two-day conference will gather over 40 speakers and 200 attendees, featuring innovative start-up flash presentation sessions designed to spark new ideas and development. Programme topics span the role of the microbiome in health and disease, including the impact of diet and nutrition, pre-, pro- and postbiotics, and emerging insights into the gut-brain axis and other body sites.

Sessions also cover microbiome-based therapeutics, technological advances such as AI, machine learning and bioinformatics, as well as skin health, ageing, hydration, and the hair and scalp microbiome. Cross-disciplinary approaches and environmental influences on the skin microbiome complete the programme.

Date: 29-30 April 2026

Location: Singapore

3rd Global Cell and Gene Therapy Summit 2026

06th July 2026 - 08th July 2026

The 3rd Global Cell and Gene Therapy Summit 2026 is a premier event bringing together experts, researchers, and industry leaders to explore the latest advancements in cell and gene therapy. The summit will feature thought-provoking sessions, case studies, and networking opportunities to foster innovation, collaboration, and strategic partnerships in the rapidly evolving landscape of biopharmaceutical science.

ISPE Singapore Conference & Exhibition 2026

19th August 2026 - 21st August 2026

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals. The annual meeting highlights best practices and services – from manufacturing facility design to finished product.

This is your opportunity to gather the latest updates and knowledge from your industry colleagues and subject matter experts!